Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
191M
-
Number of holders
-
545
-
Total shares
-
177M
-
Shares change
-
-8.14M
-
Total reported value, excl. options
-
$12.4B
-
Value change
-
-$694M
-
Put/Call ratio
-
0.63
-
Number of buys
-
272
-
Number of sells
-
-278
-
Price
-
$70.29
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q3 2024
filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock as of Q3 2024.
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) has 545 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177M shares
of 191M outstanding shares and own 92.51% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (22.6M shares), VANGUARD GROUP INC (19.3M shares), PRIMECAP MANAGEMENT CO/CA/ (18.9M shares), Dodge & Cox (13.9M shares), Capital Research Global Investors (10.5M shares), VIKING GLOBAL INVESTORS LP (9.75M shares), STATE STREET CORP (8.82M shares), AMERIPRISE FINANCIAL INC (4.28M shares), Elliott Investment Management L.P. (3.5M shares), and GEODE CAPITAL MANAGEMENT, LLC (3.26M shares).
This table shows the top 545 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.